Skip to main content
. 2025 May 24;23(5):869–883. doi: 10.1007/s40258-025-00977-6

Table 8.

Proportion of people on medication, mean QALYs and mean LDL-C at different thresholds – deterministic results

Threshold LDL-C (mmol/L) Mean QALYs % of people on ezetimibe at 1 year % of people on inclisiran at 1 year Mean LDL-C at 1 year (mmol/L)
4.0 5.959 1.5% 0.7% 1.91
3.1 5.973 5.9% 1.5% 1.87
2.7 5.994 13.2% 4.2% 1.79
2.4 6.021 22.4% 7.8% 1.70
2.2 6.046 31.2% 13.2% 1.60
2.0 6.078 42.3% 18.8% 1.50
1.8 6.115 50.6% 31.2% 1.35
1.5 6.174 73.9% 50.6% 1.12
1.2 6.225 88.7% 74.6% 0.92
0.8 6.253 99.6% 94.8% 0.79

Note: costs are not reported due to the confidentiality agreement on the price of inclisiran